Skip to content
Medical Health Aged Care

RACGP applauds NSW RSV immunisation rollout

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) has welcomed the New South Wales Government rolling out an RSV immunisation program for at risk infants.

It comes following reports that 9,000 babies across the state most at risk from respiratory syncytial virus, or RSV, will be eligible for the vaccination from Monday. The program will initially be offered to premature infants born after 31 October last year, as well as all Aboriginal and Torres Strait Islander infants born after that same date. Other high-risk, eligible infants including those with chronic neonatal lung disease less than 12 months of age and babies with combined immunodeficiency.

Recently, the College welcomed Western Australia becoming the first Australian jurisdiction to rollout an infant RSV immunisation and  urged Tasmania to follow suit.

RACGP NSW and ACT Chair, Dr Rebekah Hoffman, welcomed the decision.

“This decision will save lives in my home state,” she said.

“Some families may not realise that RSV is the number one cause of hospitalisation for children aged five and under. So, by immunising those infants who are particularly vulnerable to severe health impacts from RSV infection, we can keep these babies as safe as possible. Well done to the New South Wales Government for rolling out this immunisation, it will make such a difference in communities across the state.”

Respiratory syncytial virus, or RSV, is common respiratory infection which mostly affects young children, including babies. The symptoms are usually mild and manageable at home; however, some children and adults can become extremely ill and require hospital treatment. There were 127,944 RSV cases reported last year Australia-wide, causing symptoms that ranged from mild to life-threatening.

~ENDS

RACGP spokespeople are available for interview.


About us:

About the RACGP

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

 

Email: [email protected] (we will respond promptly to all media inquiries).

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 25/04/2025
  • 18:11
Elixir Medical Corporation

Elixir Medical Announces First Use of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Asia Pacific at Cardiac Vascular Sentral Kuala Lumpur (CVSKL), Malaysia

First cases completed by Dr. Tamil Selvan Muthusamy, MD, and Dr. Rosli Mohd Ali, MD, and transmitted live at TCTAP Congress in Seoul, Korea.Novel IVL technology designed to deliver calcium fragmentation for treatment of moderate to severely calcified coronary artery lesions without requiring an external energy source.MILPITAS, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced the first clinical use of its LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in the Asia Pacific region, marking a significant milestone in the device's global introduction. The procedures were successfully performed…

  • Medical Health Aged Care
  • 25/04/2025
  • 09:59
Monash University

Repurposed diabetes drug can reduce pain for those with knee arthritis and overweight or obesity: study

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found. Metformin, which is commonly prescribed to treat type 2 diabetes, reduced knee arthritis pain over six months in a clinical trial published in JAMA. The randomised clinical trial looked at whether metformin, compared to a placebo, reduced knee pain in patients withsymptomatic knee osteoarthritis (knee OA) andoverweight or obesity. The research was performed entirely as a community-based study using telehealth. Some of the 107 participants with pain from knee osteoarthritis (73…

  • Medical Health Aged Care
  • 24/04/2025
  • 21:41
UPS

UPS to Acquire Andlauer Healthcare Group for $1.6 Billion, Strengthening its Global Offerings in Complex Healthcare Logistics

Acquisition will Enhance End-to-End Capabilities and Service to Healthcare Customers Needing Temperature-Controlled Logistics Solutions in North America ATLANTA–BUSINESS WIRE– UPS(NYSE: UPS) today announced that…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.